2017
About FDA's Biomarker Qualification Program
Entrant Company
Palladian Partners
Category
Video / Online Video - Science (New)
Client's Name
U.S. Food and Drug Administration (FDA)
Country / Region
United States
Dr. Janet Woodcock, Director of FDA’s Center for Drug Evaluation and Research, delves into how and why CDER’s Biomarker Qualification Program supports the development of biomarkers by different groups and the benefits of the qualification process for regulatory decision-making and public adoption of new biomarkers.
Credits
Entrant Company
Unleashed Technologies
Website - Manufacturing
Country / Region
United States
Entrant Company
Scorpion
Website - Law and Legal Services
Country / Region
United States
Entrant Company
All Knight Access
Website - Entertainment
Country / Region
United States
Entrant Company
Scorpion
Website - Law and Legal Services
Country / Region
United States